Contributors to the Guidelines
Updated March 2013
Committee for the Care of Substance Users with HIV Infection
|
Chair Chinazo O Cunningham, MD, MS Members Bruce D Agins, MD, MPH Julia H Arnsten, MD, MPH Lawrence S Brown, Jr, MD, MPH, FASAM Brenda Chabon, PhD Michael Christie, MD Nereida Ferran-Hansard, MD |
Members Marc N Gourevitch, MD, MPH Steven S Kipnis, MD, FACP, FASAM Joseph P Merlino, MD, MPA Nancy Murphy, NP Edward V Nunes, MD David C Perlman, MD Sharon Stancliff, MD Robert B Whitney, MD |
All chapters are developed, reviewed, and updated by committee consensus.
The HIV Consumer Advisory Committee (CAC) reviewed all chapters.
The Young Adults Consumer Advisory Committee (YACAC) reviewed the chapter on adolescents.
The following is a list of principal contributors and peer reviewers for each chapter.
Substance Use Screening: A Quick Reference Guide for HIV Primary Care Clinicians (Posted February 2009)
What Are These Drugs? (Updated March 2009)
Principal Contributors: Steven S Kipnis, MD, FACP, FASAM, New York State Office of Alcoholism and Substance Abuse Services, Orangeburg, and Albany Medical College, Albany; Sharon Stancliff, MD, Harm Reduction Coalition, New York
Screening and Ongoing Assessment for Substance Use (Updated November 2007)
Principal Contributor: Barbara Chaffee, MD, MPH, United Health Services, Binghamton
Peer Reviewers: Thomas F Babor, PhD, MPH, The Alcohol Research Center at the University of Connecticut School of Medicine, Farmington; Joseph Conigliaro, MD, MPH, VA Pittsburgh Healthcare System, and the University of Pittsburgh School of Medicine, Pittsburgh
Working With the Active User (Updated October 2006)
Principal Contributors: Nancy Murphy, NP, St Luke’s Roosevelt Hospital Center, and CUNY Graduate Center, New York; Robert B Whitney, MD, Erie County Medical Center, Buffalo; Sharon Stancliff, MD, Harm Reduction Coalition, New York
Peer Reviewers: Chinazo O Cunningham, MD, Montefiore Medical Center, Bronx; Kumara Singaravelu, MBBS, MPH, New York County Health Services Review Organization, New York
Substance Use Treatment Modalities for HIV-Infected Substance Users (Posted January 2008)
Principal Contributors: Sharon Stancliff, MD, Harm Reduction Coalition, New York; Marc N Gourevitch, MD, MPH, New York University School of Medicine, New York; Jeffrey Rothman, New York State Department of Health AIDS Institute, New York
Peer Reviewer: Deborah Brotman, MD, Center For Comprehensive Health Practice, New York
Clinical Management of Alcohol Use and Abuse in HIV-Infected Patients (Posted April 2008)
Principal Contributor: Joseph Conigliaro, MD, MPH, VA Pittsburgh Healthcare System, and the University of Pittsburgh School of Medicine, Pittsburgh
Peer Reviewers: Thomas Kresina, PhD, National Institute on Drug Abuse, Bethesda; Richard Saitz, MD, MPH, Boston University School of Medicine, Boston
Smoking Cessation in HIV-Infected Patients (Updated February 2008)
Principal Contributor: Julia H Arnsten, MD, MPH, Montefiore Medical Center, Bronx
Peer Reviewers: Alvaro Carrascal, MD, MPH, New York State Department of Health, Albany; Kimber P Richter, PhD, MPH, University of Kansas Medical Center, Kansas City
Aspects of Primary Care for the HIV-Infected Substance User (Updated July 2010)
Principal Contributors: David C Perlman, MD, Beth Israel Medical Center, and National Development and Research Institutes, New York, and Albert Einstein College of Medicine, Bronx; Sharon Stancliff, MD, Harm Reduction Coalition, New York
Peer Reviewers: Vladimir Poznyak, MD, PhD, World Health Organization; Jeffrey Samet, MD, MA, MPH, Boston University School of Medicine, Boston
Adherence to Antiretroviral Therapy Among Substance Users (Updated June 2005)
Principal Contributor: Julia H Arnsten, MD, MPH, Montefiore Medical Center, Bronx
Peer Reviewers: David Bangsberg, MD, MPH, University of California, San Francisco; Lois Eldred, DrPH, The Health Resources and Services Administration, HIV/AIDS Bureau, Rockville
Drug-Drug Interactions Between ARV Agents, Medications Used in Substance Use Treatment, and Recreational Drugs (Updated March 2008)
Principal Contributors: John J Faragon, PharmD, Albany Medical Center, Albany; Paul Pham, PharmD, The Johns Hopkins University, Baltimore
Peer Reviewer: Elinore F McCance-Katz, MD, PhD, Virginia Commonwealth University, Richmond
Pain in the HIV-Infected Substance User (Updated August 2005)
Principal Contributor: Robert B Whitney, MD, Erie County Medical Center, Buffalo
Peer Reviewers: William S Breitbart, MD, Memorial Sloan-Kettering Cancer Center, New York; Andrew Rosenblum, PhD, National Development and Research Institutes, New York
Mental Health Disorders Among Substance-Using HIV-Infected Patients (Posted March 2008)
Principal Contributors: Steven L Batki, MD, SUNY Upstate Medical University, Syracuse; John AR Grimaldi, Jr, MD, New York-Presbyterian Hospital/Weill Cornell Medical Center, New York
Peer Reviewers: Marshall Forstein, MD, The Cambridge Hospital, Cambridge; George E Woody, MD, University of Pennsylvania, and the Philadelphia VA Medical Center, Philadelphia
Medical Care of HIV-Infected Substance-Using Women (Updated February 2009)
Principal Contributors: Diane M Rudnick, MEd, New York State Department of Health AIDS Institute, New York; Sharon Stancliff, MD, Harm Reduction Coalition, New York
Peer Reviewers: Hillary Kunins, MD, MPH, Montefiore Medical Center, Bronx; Barbara C Zeller, MD, Project Samaritan AIDS Services, Bronx
Care of the Hospitalized HIV-Infected Substance User (Posted March 2009)
Principal Contributors: Brenda Chabon, PhD, Montefiore Medical Center, Bronx; Eunmee H Chun, MD, New York State Department of Health AIDS Institute, New York; Barbara Chaffee, MD, MPH, United Health Services, Binghamton
Peer Reviewers: Sheree Starrett, MD, Casa Promesa, Bronx; Stanley R Yancovitz MD, Beth Israel Medical Center, New York
Substance Use and Dependence Among HIV-Infected Adolescents and Young Adults (Posted February 2009)
Principal Contributors: Katherine Marx, NP, SUNY Downstate Medical Center, Brooklyn; Jeffrey M Birnbaum, MD, SUNY Downstate Medical Center, Brooklyn; Brenda Chabon, PhD, Montefiore Medical Center, Bronx; Steven J Lee, MD, Columbia University, New York
Peer Reviewers: David L Bell, MD, Columbia University, New York; Randolph D Muck, MEd, Center for Substance Abuse Treatment, Rockville, Maryland
Appendix I: Criteria for Substance Dependence (Updated January 2008)
Appendix II: Common Screening Tools for Identifying Substance and Alcohol Problems (Updated November 2007)
Appendix III: The Fagerstrom Test for Nicotine Dependence (Updated February 2008)
Appendix IV: Organizations Providing Co-Located HIV Care Within Drug Treatment Facilities (Updated January 2009)
Appendix V: AIDS Institute-Funded Harm-Reduction Programs (Posted January 2009)
Appendix VI: Guidance on the Use of Buprenorphine in HIV-Infected Patients (Posted February 2009)
Principal Contributors: Sharon Stancliff, MD, Harm Reduction Coalition, New York; Marc N Gourevitch, MD, MPH, New York University School of Medicine, New York; Eunmee H Chun, MD, New York State Department of Health AIDS Institute, New York
Appendix VII: Antiretroviral Therapy: Hepatic Impairment Dosing (Updated April 2010)
Appendix VIII: Drugs Used for Smoking Cessation (Updated July 2009)
Appendix IX: New York State Adherence Services Contact List (Updated February 2009)
Appendix X: Advantages and Disadvantages of Adherence Measures (Updated June 2005)
Appendix XI: Opioid Medication Interactions (Updated February 2009)
Appendix XII: Drug Interactions Between ARV Agents and Recreational Drugs (Updated February 2009)
Appendix XIII: Interactions Between HIV-Related Medications and Psychotropic Medications (Updated April 2010)
Appendix XIV: Identification and Management of Withdrawal Symptoms (Posted March 2009)


Facebook Twitter LinkedIn